- Home
- SEER vs SRTS Comparison
SEER vs SRTS Comparison
Compare SEER & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- SRTS
- Stock Information
- Founded
- SEER 2017
- SRTS 2010
- Country
- SEER United States
- SRTS United States
- Employees
- SEER N/A
- SRTS N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- SRTS Medical/Dental Instruments
- Sector
- SEER Health Care
- SRTS Health Care
- Exchange
- SEER Nasdaq
- SRTS Nasdaq
- Market Cap
- SEER 105.0M
- SRTS 90.5M
- IPO Year
- SEER 2020
- SRTS 2016
- Fundamental
- Price
- SEER $1.77
- SRTS $6.07
- Analyst Decision
- SEER Hold
- SRTS Strong Buy
- Analyst Count
- SEER 1
- SRTS 2
- Target Price
- SEER $3.00
- SRTS $10.00
- AVG Volume (30 Days)
- SEER 306.8K
- SRTS 157.0K
- Earning Date
- SEER 11-05-2024
- SRTS 11-07-2024
- Dividend Yield
- SEER N/A
- SRTS N/A
- EPS Growth
- SEER N/A
- SRTS 179.87
- EPS
- SEER N/A
- SRTS 0.41
- Revenue
- SEER $14,738,000.00
- SRTS $36,366,000.00
- Revenue This Year
- SEER N/A
- SRTS $54.75
- Revenue Next Year
- SEER $43.19
- SRTS $22.06
- P/E Ratio
- SEER N/A
- SRTS $14.91
- Revenue Growth
- SEER N/A
- SRTS 20.99
- 52 Week Low
- SEER $1.46
- SRTS $1.79
- 52 Week High
- SEER $2.48
- SRTS $7.18
- Technical
- Relative Strength Index (RSI)
- SEER 59.85
- SRTS 48.01
- Support Level
- SEER $1.65
- SRTS $5.90
- Resistance Level
- SEER $1.75
- SRTS $6.25
- Average True Range (ATR)
- SEER 0.06
- SRTS 0.36
- MACD
- SEER 0.02
- SRTS -0.03
- Stochastic Oscillator
- SEER 83.90
- SRTS 51.63
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.